VeinSee 2.0: Redefining IV Access
Intravenous access involves inserting a needle into a vein to withdraw blood for testing or administrate medical fluids or treatments for therapeutic or diagnostic purposes, with or without a cannula.
Although intravenous access is typically a simple procedure, it can become more complex due to a number of factors. All of these variables, including skin color, the fragility of infant skin, a history of drug addiction, and others, can affect the visibility of veins and make locating them difficult.
The occurrence of intravenous access difficulties is a prevalent obstacle for many healthcare professionals.
Typically, two to three attempts are required to effectively establish a peripheral IV site in a patient. Research indicates that hard intravenous access occurs in approximately 10% to 30% of emergency department patients. When dealing with patients with difficult venous access, even the most experienced nurses and physicians may struggle to locate suitable vessels.
It can be frustrating and anxiety-inducing for healthcare professionals to struggle with a difficult IV start, particularly when their primary objective is to minimize the patient’s discomfort. There is, thankfully, a way to alleviate this tension.
The VeinSee 2.0 Portable Infrared Vein Finder makes use of the varying absorption rates of near-infrared light. This innovative technology is intended to aid medical professionals in identifying and evaluating appropriate veins, even in patients with the most difficult venous access.
VeinSee 2.0 designed for use on patients with dark skin tones, obesity, or narrow blood vessels. They include a variety of accessories that meet the requirements of both the healthcare provider and the patient. These devices emanate light that illuminates veins beneath the skin’s surface, enhancing vein visibility significantly.
Vein finders are extremely important in all areas of medicine because they facilitate intravenous access, making it safer, more efficient, and less painful for patients.